Telomeres are transcribed in long noncoding RNA named TERRA. Although TERRA functions have been extensively investigated, the role of TERRA in telomerase recruitment and regulation is still elusive. In this issue of EMBO Reports, Moravec et al report in Schizosaccharomyces pombe that telomere shortening induces the expression of TERRA [1] . They show that polyadenylated TERRA molecules specifically associate with the telomerase catalytic subunit and stimulate telomerase-mediated elongation of the telomere from which the TERRA molecules originate. Strikingly, their results indicate that shaping the 3 0 end of telomere transcripts controls telomerase activity.
See also: M Moravec et al (July 2016)
T elomeres consist of DNA repeats associated with proteins, which constitutes a peculiar form of chromatin that protects the ends of chromosomes from degradation, fusion, and activation of DNA damage responses. Telomeres comprise arrays of G-rich tandem DNA repeats with a single-stranded extension on the 3 0 strand called G-tail. Telomeric DNA is bound by the shelterin complex that bridges the duplex telomeric DNA to the G-tail. Various combinations of this canonical structure are found in different organisms. In contrast to yeast telomeres that adopt a non-nucleosomal chromatin structure, mammalian telomeric chromatin contains arrays of shelterin complexes flanked by nucleosomes. Despite these differences, telomeres and subtelomeric regions are heterochromatic in nature and create a transcriptionally repressive chromatin environment. In spite of this, telomeres were found to be transcribed by RNA polymerase II, which reads the C-rich telomeric strand to generate G-rich telomeric repeat-containing RNA, called TERRA [2] . Transcription of TERRA starts within the adjacent subtelomeric sequences and includes a variable number of telomeric Grich sequences. TERRA was initially discovered in mammalian cells and then in other eukaryotes including budding yeast, zebrafish, and plants [3] . TERRA transcripts have been proposed to have several functions including telomeric heterochromatin formation, capping of chromosome ends, telomere replication, and regulation of telomerase activity; however, their precise molecular roles remain to be carefully elucidated. Moreover, conflicting data have been reported regarding the localization of TERRA and its role in telomerase recruitment and activity. For instance, in budding yeast accumulation of TERRA induced by the inactivation of the Rat1 5 0 to 3 0 exonuclease affected telomerase-mediated telomere elongation [4] , while in another study TERRA molecules were proposed to participate in telomerasedependent elongation of the transcribed telomere by aggregating telomerase molecules at short telomeres [5, 6] . Similarly, human TERRA was shown in vitro to be a natural ligand and direct inhibitor of human telomerase [7, 8] ; however, overexpression of TERRA in cells lacking the two DNA methyltransferases DNMT1 and DNMT3b did not affect telomerase activity [9] . These examples point out the need for unifying models integrating all these observations. [10] . In the paper in this issue, the authors first show that telomere shortening induces the expression of TERRA in S. pombe as previously reported in budding yeast. However, in contrast to budding yeast only a subset of these TERRA molecules are polyadenylated. Strikingly, these polyadenylated TERRA molecules that are characterized by the presence of very short telomeric tracts at their 3 0 end associate in RNA immunoprecipitation (RIP) experiments with telomerase in a way that is independent of telomerase RNA. Although there is no direct evidence that the catalytic subunit of telomerase binds TERRA directly, this raises the intriguing questions as to what the molecular basis of this interaction is and why telomerase or its associated proteins interact only with polyadenylated TERRA with short telomeric tracts. The authors further generate a transcriptionally inducible telomere (tiTEL) in order to force the transcription of one given telomere. With this experimental setting, induction of the expression of tiTEL produces higher amounts of polyadenylated tiTERRA than G-rich tiTERRA. The polyadenylated tiTERRA was found to associate with telomerase, and expression of tiTERRA leads to the specific elongation of the transcribed telomere in a telomerase-dependent manner without affecting the length of other telomeres. From these data, Moravec et al propose a model whereby shortening of telomeres and consecutive loss of Rap1 repression would increase TERRA transcription and release of polyadenylated TERRA into the nucleoplasm, where it would interact with telomerase and bring it back to its telomere of origin. In agreement with the model suggested by Cusanelli et al in budding yeast, interaction of telomerase with polyadenylated TERRA would promote telomerase recruitment and elongation of the telomere from which the TERRA molecules originate. Two main questions remain to be answered. First, is the interaction between polyadenylated TERRA and the catalytic subunit of telomerase direct? This question could be solved by the use of the CRAC method (cross-linking and analysis of cDNA) developed by Markus Bohnsack to identify potential interaction sites of telomerase with polyadenylated TERRA. The second question is how is polyadenylated TERRA with short telomeric tracts generated?
Overall, the work by Moravec has three important merits: (i) It shows that polyadenylated TERRA interacts with telomerase, (ii) it provides evidence that telomere transcription stimulates telomerase-mediated telomere elongation in cis in an organism with human-like telomeres, and (iii) it proposes that different TERRA molecules may have opposing effects on telomerase activity. In Fig 1, we speculate how transcription termination could shape the 3 0 ends of TERRA transcripts and lead to different TERRA molecules with opposing effects. TERRA molecules processed by the cleavage and polyadenylation factor (CPF)-cleavage factor (CF) complex would generate polyadenylated TERRA with no (or very short) telomeric sequences. These polyadenylated TERRA molecules would promote telomerase activity by nucleating telomerase at chromosome ends. Other pathways involved in TERRA termination-that remain to be determined-could generate TERRA with long telomeric tracts that would exert an inhibitory effect on telomerase. This hypothesis could reconcile some of the apparently conflicting results described above. After many efforts to understand how TERRA transcription is initiated, this work from Azzalin and co-workers points out the need to determine the mechanisms underlying TERRA transcription termination. In response to telomere erosion, Rap1 is released from telomeres, and G-rich TERRA transcription is induced. G-rich TERRA molecules exert an inhibitory effect on telomerase by competing with telomeres for telomerase binding. Moravec et al show that G-rich TERRA molecules are cleaved and polyadenylated, presumably by CPF-CF, thereby generating polyadenylated TERRA molecules containing few or no telomeric sequences. In this scenario, the G-rich TERRA would be degraded by the 5 0 -3 0 exoribonuclease Dhp1/Rat1/Xrn2. The polyadenylated TERRA generated by the termination pathway interacts with the catalytic subunit of telomerase and promotes the nucleation of telomerase at the transcribed telomere. As a result, the short telomere is specifically elongated. In this model, we expect mutations affecting the exoribonuclease activity to inhibit telomerase activity. 
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